Natera Is Maintained at Outperform by Baird
NTRA sits 72% above its 52-week low of $125.38.
Summary
Baird has maintained its 'Outperform' rating on Natera and raised its price target to $257.00 per share from $239.00. This positive analyst action follows Natera's announcement yesterday of strong Q4 and full year 2025 financial results, which likely prompted the revised valuation. The increased price target from a reputable firm reinforces a positive outlook on the company's prospects and could provide upward momentum for the stock as investors react to the analyst's updated conviction. Traders will be watching for further analyst coverage and the company's continued operational performance.
At the time of this announcement, NTRA was trading at $216.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.9B. The 52-week trading range was $125.38 to $256.36. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.